Get the Daily
AfterRaise/Today/9 September 2026

AfterRaise daily

9 September 2026 on AfterRaise

19 companies raised $1.4B in disclosed rounds of $5M or more. Every figure links to its source, and every company page follows what happens next.

19companies raised yesterday LiveNew+147% vs 7-day average41raised in the last 7 days Live-40% vs last week5US expansion signals this month AfterRaise intelligence22companies stated hiring plans this month AfterRaise intelligence588open roles Public signal
FundingPublic signalyesterday
Encoded Therapeutics
$275M · Series F · South San Francisco, USA · Biotech & Pharma
What changed

Raised $275M in Series F funding, led by GV and another healthcare fund.

The company said the funding supports support the pivotal study of ETX101 in infants and young children with SCN1A+ Dravet syndrome, an expansion study in children and adolescents up to 18 years of age, commercial scale-up of internal GMP manufacturing capabilities, and pipeline advancement, including ETX301 toward a 2027 IND submission for post-amputation neuroma pain.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical operationsCMC and manufacturingQuality systemsScientific hiringLicensing and BD partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Celero Communications
$275M · Series C · Irvine, USA · AI & Data Infrastructure
What changed

Raised $275M in Series C funding, led by Atreides Management.

The company said the funding supports accelerate its product roadmap, R&D investments, and production readiness for higher-bandwidth, lower-power optical connectivity across next-generation AI infrastructure.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringResearch programme expansion
Where help may be relevant AfterRaise intelligenceInfrastructure and computeSecurity reviewData partnershipsProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Cylake
$245M · Undisclosed · Sunnyvale, USA · Cybersecurity
What changed

Raised $245M.

The company said the funding supports support continued product development for its complete, AI-native, fully sovereign cybersecurity platform, as well as ongoing team growth.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceChannel partnershipsThreat intelligence partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Solstice Oncology
$225M · Series A · Boston, USA · Biotech & Pharma
What changed

Raised $225M in Series A funding, led by RA Capital Management.

The company said the funding supports advance its lead candidate, porustobart, across two clinical indications.

Likely next AfterRaise intelligenceResearch programme expansionScientific team growthAggressive multi-front expansion
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringScientific advisersResearch operationsSpecialist suppliers
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Savvy Wealth
$100M · Series C · NYC, USA · Fintech & Insurance
What changed

Raised $100M in Series C funding, led by Halo Fund.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceBanking partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsProduct leadership
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
TwoStep Therapeutics
$62M · Series A · San Carlos, USA · Biotech & Pharma
What changed

Raised $62M in Series A funding.

The company said the funding supports advance its lead multi-specific peptide-drug conjugate, TS-104, through Phase 1 clinical development in oncology, advance its radioligand program, and expand into new peptide conjugates.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical operationsScientific hiringLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Bluecore Energy
$50M · Seed · Long Beach, USA · Energy & Climate
What changed

Raised $50M in Seed funding, led by Silverton Partners.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceAccelerated hiring across functionsFounding team growthFirst commercial motion
Where help may be relevant AfterRaise intelligenceRegulatory affairsGrid and utility partnershipsProject financeField operationsCertification
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Implicity
$40M · Undisclosed · Paris, France · AI & Data Infrastructure
What changed

Raised $40M, led by IRIS.

The company said the funding supports expand its commercial footprint and hospital network in the US, support commercial hiring, develop US-specific platform features, and advance its AI innovation roadmap, including next-generation heart failure prediction algorithms.

Likely next AfterRaise intelligenceUS market entryTeam growth across core functionsSenior leadership appointments
Where help may be relevant AfterRaise intelligenceInfrastructure and computeEnterprise salesData partnershipsProduct leadershipExecutive search
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Wint
$36M · Series D · NYC, USA · Other
What changed

Raised $36M in Series D funding, led by LIP Ventures and Inven Capital.

The company said the funding supports accelerate product development and consolidate its market position.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringAcquisitions and consolidation
Where help may be relevant AfterRaise intelligenceCommercial leadershipGo-to-market partnershipsFinance and complianceProduct leadershipDesign partners
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Neurent Medical
$25M · Undisclosed · USA · Healthcare & Medtech
What changed

Raised $25M.

The company said the funding supports support the continued commercial expansion, accelerate investment in sales and marketing initiatives, strengthen its balance sheet, and provide additional capital to support future growth opportunities.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceClinical hiringProvider partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Euno
$23M · Series A · USA · Other
What changed

Raised $23M in Series A funding, led by N47.

The announcement did not set out what the funding supports.

Likely next AfterRaise intelligenceRepeatable go-to-market buildFirst senior commercial hires
Where help may be relevant AfterRaise intelligenceCommercial leadershipOperations hiringGo-to-market partnershipsFinance and compliance
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
System
$20M · Undisclosed · San Francisco, USA · Biotech & Pharma
What changed

Raised $20M.

The company said the funding supports accelerate its expansion and build the foundation and infrastructure for its peptide supply chain.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceCMC and manufacturingQuality systemsLicensing and BD partnershipsMarket-entry advisersLocal employment infrastructure
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Fundcraft
€12M · Undisclosed · Luxembourg, Luxembourg · Enterprise Software
What changed

Raised €12M, led by Riverside Acceleration Capital and CCAP Investments.

The company said the funding supports accelerate momentum across its existing European client base and core markets, expand into additional jurisdictions, deepen capabilities in institutional private equity buyout strategies, and continue executing its AI strategy.

Likely next AfterRaise intelligenceEuropean market entryNew market entryFirst local hires in the new market
Where help may be relevant AfterRaise intelligenceCloud infrastructureChannel partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Harmoni
$10M · Series A · USA · Other
What changed

Raised $10M in Series A funding, led by Bessemer Venture Partners.

The company said the funding supports accelerate the platform's development and expand its team.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceCommercial leadershipGo-to-market partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Actionable
$10M · Undisclosed · Paris, France · AI & Data Infrastructure
What changed

Raised $10M, led by Hi Inov.

The company said the funding supports expand its product, data engineering, and sales teams, scale its automated international reseller partner networks, and accelerate its commercial market entry into the United States.

Likely next AfterRaise intelligenceUS market entryNew market entryFirst local hires in the new market
Where help may be relevant AfterRaise intelligenceInfrastructure and computeEnterprise salesData partnershipsProduct leadershipMarket-entry advisers
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
ZeroRisk
$10M · Series A · Dublin, Ireland · Fintech & Insurance
What changed

Raised $10M in Series A funding, led by MiddleGame Ventures.

The company said the funding supports support its global expansion, further product development, and the operational capacity needed to deploy the platform across large merchant portfolios.

Likely next AfterRaise intelligenceGlobal market entryNew market entryFirst local hires in the new market
Where help may be relevant AfterRaise intelligenceBanking partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsProduct leadership
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Bulwark Dynamics
$7M · Seed · Menlo Park, USA · Other
What changed

Raised $7M in Seed funding.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceGo-to-market partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnershipsCommercial leadership
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
Overroute
$6M · Undisclosed · Lowell, USA · Logistics & Mobility
What changed

Raised $6M, led by UP.Partners.

The company said the funding supports expand operations and its development efforts.

Likely next AfterRaise intelligenceNew market entryFirst local hires in the new marketLocal entity and legal setup
Where help may be relevant AfterRaise intelligenceCarrier and network partnershipsInfrastructure partnershipsMarket-entry advisersLocal employment infrastructureIn-market partnerships
Approach preferences not yet specified
Company pageSource
FundingPublic signalyesterday
MCatalysis
$5M · Seed · London, UK · Enterprise Software
What changed

Raised $5M in Seed funding, led by HL Energy Ventures and Oxford Science Enterprises.

The company said the funding supports construct an industrial pilot facility at the Axel'One platform in Lyon, France, while continuing R&D operations in London.

Likely next AfterRaise intelligenceProduct launches and new tiersProduct leadership hiringResearch programme expansion
Where help may be relevant AfterRaise intelligenceRevenue operationsChannel partnershipsProduct leadershipDesign partnersSpecialist engineering
Approach preferences not yet specified
Company pageSource

The Daily Brief

This page, in your inbox.

Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.